Marco Guevara-Aguirre
USFQ
80
Coauthors
10
Documentos
10
H-index Scopus
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2006 | 1 |
2007 | 2 |
2011 | 1 |
2012 | 2 |
2013 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Genética | 5 |
Medicina interna | 3 |
Obesidad | 3 |
Medicamento | 2 |
Diabetes | 2 |
Bioquímica | 1 |
Pediatría | 1 |
Fisiología | 1 |
Antropología | 1 |
Migración humana | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Fisiología humana | 9 |
Enfermedades | 8 |
Ginecología, obstetricia, pediatría, geriatría | 2 |
Farmacología y terapéutica | 2 |
Salud y seguridad personal | 2 |
Medicina forense; incidencia de enfermedades | 1 |
Cultura e instituciones | 1 |
Bioquímica | 1 |
Mammalia | 1 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 10 |
Google Scholar | 2 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
Jaime Guevara-Aguirre | 10 |
Rosenbloom A.L. | 6 |
Saavedra J. | 6 |
Procel P. | 4 |
Ostrer H. | 3 |
Carolina Guevara | 3 |
Rosenfeld R.G. | 2 |
Hwa V. | 2 |
Oddoux C. | 2 |
Kerns S.L. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Absence of hypoglycemia in response to varying doses of recombinant human insulin-like growth factor-I (rhIGF-I) in children and adolescents with low serum concentrations of IGF-I
ArticleAbstract: Aim: To determine whether recombinant human insulin-like growth factor-I (rhIGF-I) administration toPalabras claves:Growth hormone insensitivity, Insulin-like growth factor binding protein-3, Short statureAutores:Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Rosenbloom A.L.Fuentes:scopusComparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes
ArticleAbstract: Background: The aim of this study was to compare the glucose pharmacodynamics after oral spray insulPalabras claves:Autores:Bernstein G., Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Rosenbloom A.L., Saavedra J.Fuentes:scopusRecommended IGF-I dosage causes greater fat accumulation and osseous maturation than lower dosage and may compromise long-term growth effects
ArticleAbstract: Context: The maximum dose of IGF-I recommended for treatment of GH insensitivity is commonly used. OPalabras claves:Autores:Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Procel P., Rosenbloom A.L., Saavedra J.Fuentes:scopusDespite higher body fat content, Ecuadorian subjects with Laron syndrome have less insulin resistance and lower incidence of diabetes than their relatives
ArticleAbstract: In the present pandemics of obesity and insulin resistant diabetes mellitus (DM), the specific contrPalabras claves:Growth hormone, Growth hormone receptor, Growth hormone receptor deficiency, Laron syndromeAutores:Carolina Guevara, Enrique Terán, Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Procel P., Rosado V.Fuentes:googlescopusEffects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature
ArticleAbstract: Context & objective: The Ecuadorian GH receptor deficiency (GHRD)/Laron syndrome population is the oPalabras claves:GH receptor deficiency, growth, IGF-I, IGFBP-3, Laron syndromeAutores:Baumbach L., Jaime Guevara-Aguirre, Marco Guevara-Aguirre, Rosenbloom A.L., Saavedra J., Shuster J., Yariz K.Fuentes:scopus